5490-76-6

Basic information

• Product Name: (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol
• Synonyms: (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol
• CAS NO: 5490-76-6
• Molecular Weight: 340.463
• Mol File: 5490-76-6.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol(5490-76-6)
• EPA Substance Registry System: (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol(5490-76-6)

Safety Data

• Hazardous Substances Data: 5490-76-6(Hazardous Substances Data)

Usage

Description

(8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol is a complex steroid compound characterized by its cyclopenta[a]phenanthrene core structure and a dioxolan ring. It features an ethynyl group, a methyl group, and a hydroxyl group at position 17, with the spiro dioxolan ring adding to its intricate molecular architecture. This unique structure suggests potential for significant biological activity and interactions with various hormone receptors and biological targets, indicating its promise for pharmaceutical applications.

Uses

Used in Pharmaceutical Industry:
(8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol is used as a potential pharmaceutical agent for its likely ability to interact with hormone receptors and other biological targets. Its complex structure and the presence of functional groups make it a candidate for the development of new drugs targeting various medical conditions.
Used in Research and Development:
In the field of chemical and biological research, (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol serves as a subject for studying the effects of its unique structural features on biological activity. Researchers may utilize this compound to explore new mechanisms of action and potential therapeutic applications.
Used in Drug Design and Synthesis:
(8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol is employed in drug design and synthesis efforts, where its structural elements can be manipulated to create novel compounds with specific biological activities. (8S,13S,14S,17R)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2’-[1,3]dioxolan]-17-ol's ethynyl and hydroxyl groups, in particular, may be key in the development of new pharmaceutical agents.

Downstream Products

• 42982-49-0 3,3-[1,2-ethanediylbis(oxy)]-17α-hydroxy-19-norpregna-5(10),9(11)-diene-20-one 
• 54201-83-1 5α,10α-epoxy-17α-hydroxy-19-norpregn-9(11)-ene-3,20-dione 3,20-bis(ethylene acetal) 
• 54201-84-2 17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal) 
• 126784-99-4 ulipristal acetate 
• 159811-51-5 CDB-3236 
• 196881-39-7 C₄₀H₄₅NO₇ 
• 196881-38-6 C₃₆H₄₀O₈S 
• 196881-37-5 C₃₇H₄₅NO₆S 
• 162607-85-4 C₃₈H₄₈N₂O₄ 
• 91934-88-2 C₃₆H₄₃NO₄ 
• 91934-95-1 3,3-ethylenedioxy-5α,17β-dihydroxy-11β-[4-(N,N-dimethylamino)phenyl]-19-nor-17α-pregn-9-ene-21-ethyne